Retosiban structure
|
Common Name | Retosiban | ||
---|---|---|---|---|
CAS Number | 820957-38-8 | Molecular Weight | 494.58300 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C27H34N4O5 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of RetosibanRetosiban (GSK221149A) is a potent and selective oxytocin antagonist with a Ki of 0.65 nM. |
Name | (3R,6R)-6-[(2S)-butan-2-yl]-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2-methyl-1,3-oxazol-4-yl)-2-morpholin-4-yl-2-oxoethyl]piperazine-2,5-dione |
---|---|
Synonym | More Synonyms |
Description | Retosiban (GSK221149A) is a potent and selective oxytocin antagonist with a Ki of 0.65 nM. |
---|---|
Related Catalog | |
Target |
IC50: 0.65 nM (Oxytocin)[1] |
References |
Molecular Formula | C27H34N4O5 |
---|---|
Molecular Weight | 494.58300 |
Exact Mass | 494.25300 |
PSA | 108.47000 |
LogP | 2.19130 |
Storage condition | 2-8°C |
~% Retosiban CAS#:820957-38-8 |
Literature: GLAXO GROUP LIMITED Patent: WO2005/840 A1, 2005 ; Location in patent: Page/Page column 12-13 ; WO 2005/000840 A1 |
Detail
|
Literature: GLAXO GROUP LIMITED Patent: WO2005/840 A1, 2005 ; Location in patent: Page/Page column 13-15 ; WO 2005/000840 A1 |
UNII-GIE06H28OX |
Retosiban |